These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31526534)

  • 1. [Multiple cutaneous squamous cell carcinoma after treatment with ingenol mebutate].
    Chabbert C; Levy M; Legrand L
    Ann Dermatol Venereol; 2019 Dec; 146(12):823-825. PubMed ID: 31526534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rapidly growing squamous cell carcinoma after ingenol mebutate treatment].
    Ehret M; Velter C; Tebacher M; Bruant-Rodier C; Cribier B
    Ann Dermatol Venereol; 2018 Oct; 145(10):607-612. PubMed ID: 29779859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma developed after ingenol mebutate therapy: a possible consequence of the treatment?
    Maglie R; Grandi V; Maio V; Pileri A
    G Ital Dermatol Venereol; 2018 Jun; 153(3):442-443. PubMed ID: 29766707
    [No Abstract]   [Full Text] [Related]  

  • 4. Local skin reactions following the administration of topical ingenol mebutate for actinic keratosis.
    Conde-Taboada A; Mercado B; Aranegui B; González-Guerra E; López-Bran E
    Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
    Abramovits W; Oquendo M; Vincent KD; Gupta AK
    Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
    Erlendsson AM
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ingenol Mebutate and the Treatment of Actinic Keratosis.
    Heron CE; Feldman SR
    J Drugs Dermatol; 2021 Jan; 20(1):102-104. PubMed ID: 33400406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization.
    Gaide O; Clayton H; Girardin M; Kuonen F
    Dermatology; 2016; 232 Suppl 1():7-8. PubMed ID: 27513862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
    Bettencourt MS
    J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases.
    Moreno Romero JA; Campoy A; Perez N; Garcia F; Grimalt R
    Br J Dermatol; 2015 Dec; 173(6):1514-7. PubMed ID: 26227007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bowenoid Actinic Keratosis and Bowen's Disease Treated Successfully with Ingenol Mebutate.
    Mohanna MT; Hofbauer GF
    Dermatology; 2016; 232 Suppl 1():14-6. PubMed ID: 27513957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
    Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ingenol mebutate on actinic keratosis in a Korean population: A prospective clinical, dermoscopic and histopathological study from a single center.
    Kim JS; Woo YR; Kim M; Park HJ
    J Dermatol; 2018 Nov; 45(11):1324-1330. PubMed ID: 30260493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ingenol mebutate (Picato) for actinic keratosis.
    Med Lett Drugs Ther; 2012 Apr; 54(1389):35-6. PubMed ID: 22538622
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
    Berman B
    Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient.
    Mühlstädt M
    Dermatology; 2016; 232 Suppl 1():20-3. PubMed ID: 27513345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erosive pustular dermatosis of the scalp following topical ingenol mebutate for actinic keratoses.
    Vaccaro M; Borgia F; Gasco L; Cannavò SP
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28685901
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP).
    Tzogani K; Nagercoil N; Hemmings RJ; Samir B; Gardette J; Demolis P; Salmonson T; Pignatti F
    Eur J Dermatol; 2014; 24(4):457-63. PubMed ID: 25115145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.